Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation

por De Heide, John, Vroegh, Christiaan J., Bhagwandien, Rohit E., Wijchers, Sip A., Szili-Torok, Tamas, Zijlstra, Felix, Lenzen, Mattie J., Yap, S. C.
Publicado 2018